Rock Springs Capital Management LP

BALTIMORE, MD · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$1.86B2026 Q3
Positions107
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.42.9%

Rock Springs Capital Management LP reported 107 positions worth $1.86B as of September 30, 2026 (13F filed November 16, 2026). Largest holding: RVMD (9.6%). Biggest move: reduce RVMD ($48.4M).

10 / 107 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 RVMDRevolution Medicines$178.4M9.59%869,256——-20.7%
▸ 2 TVTXTravere Therapeutics$129.8M6.98%2,204,085——-15.6%
▸ 3 LLYEli Lilly$114.2M6.14%98,700——+22.3%
▸ 4 MDGLMadrigal Pharmaceuticals$89.3M4.80%177,249——-15.9%
▸ 5 MIRMMirum Pharmaceuticals$66.7M3.58%779,790——+7.1%
▸ 6 RYTMRhythm Pharmaceuticals$65.9M3.55%692,598——+22.5%
▸ 7 KYMRKymera Therapeutics$45.8M2.46%409,631——+8.7%
▸ 8 INSMInsmed$41.7M2.24%365,250——+6.8%
▸ 9 UNHUnitedHealth$33.9M1.82%92,250——+6.2%
▸ 10 SRRKScholar Rock$33.0M1.77%682,654——-7.8%

Pro Feature

The remaining 97 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Rock Springs Capital Management LP hold as of Q3 2026?

Rock Springs Capital Management LP reported 107 positions worth $1.86B in its Q3 2026 13F filing. Largest positions: RVMD (9.6%), TVTX (7.0%), LLY (6.1%), MDGL (4.8%) and MIRM (3.6%).

What did Rock Springs Capital Management LP buy in Q3 2026?

New positions: LTGO, FRNM, ABCL, IONS and IMVT (11 in all). Added to: UNH, AMLX, BBIO, OMER and NVO (34 in all).

What did Rock Springs Capital Management LP sell in Q3 2026?

Reduced: RVMD, ARGX, PEN, ALNY and AZTA (30 in all). Sold out entirely: MDT, DNTH, ALT, SGRY and ORKA (8 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.